ProQR Therapeutics
proqr.comLocations
Leiden, Netherlands
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2012
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
Something looks off?Open jobs at ProQR Therapeutics